Over the past two decades, several studies have assessed the association between CYP2A6 polymorphism, including whole-gene deletion of CYP2A6 on allele 4 (CYP2A6*4), and the risk of lung cancer among different ethnic populations, but the results have been inconsistent12,19,20. The gene discussed is CYP2A6; the disease is lung carcinoma.